Ethyl 2-ethyl-6,6-dimethylcyclohex-2-ene-1-carboxylate
Common Name: |
Ethyl 2-ethyl-6,6-dimethylcyclohex-2-ene-1-carboxylate |
IUPAC Name: |
ethyl 2-ethyl-6,6-dimethylcyclohex-2-ene-1-carboxylate |
Molecular Formula: |
C13H22O2 |
SMILES: |
CCC1=CCCC(C1C(=O)OCC)(C)C |
Inchi: |
1S/C13H22O2/c1-5-10-8-7-9-13(3,4)11(10)12(14)15-6-2/h8,11H,5-7,9H2,1-4H3 |
Inchi Key: |
CQHUPYQUERYPML-UHFFFAOYSA-N |
Cas No: |
57934-97-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
210.31 |
Mass (g/mol) |
210.162 |
Molar Refractivity |
63.04 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
4 |
Rings |
1 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
102.00 to 103.00 @ 11.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.017 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.77 |
LogP |
3.322 |
iLOGP |
3.02 |
XLOGP3 |
3.39 |
WLOGP |
3.32 |
MLOGP |
2.92 |
ESOL Log S |
-3.02 |
ESOL Solubility (mg/ml) |
0.203 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.62 |
Ali Solubility (mg/ml) |
0.05 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.11 |
Silicos-IT Solubility (mg/ml) |
0.16 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.18 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.95 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.279 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Warning |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
0 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |